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Summary 
Defects in the gene encoding Bruton's tyrosine kinase (Btk) result in a disease  called X-linked 
agammaglobulinemia, in which there is a profound decrease of mature B cells due to a block in 
B  cell development. Recent studies have shown that Btk is tyrosine phosphorylated and acti- 
vated upon B  cell antigen receptor (BCR) stimulation. To elucidate the functions of this ki- 
nase, we examined BCR signaling ofDT40 B cells deficient in Btk. Tyrosine phosphorylation 
of phospholipase C  (PLC)--~/2 upon receptor stimulation was significantly reduced in the mu- 
tant cells, leading to the loss of  both BCK-coupled phosphatidylinositol hydrolysis and calcium 
mobilization.  Pleckstrin homology and  Src-homology 2  domains  of Btk were  required for 
PLC-~/2 activation. Since Syk is also  required for the BCK-induced PLC-~/2 activation, our 
findings indicate that PLC-~/2 activation is regulated by Btk and Syk through their concerted 
actions. 
M 
utations in the gene encoding the Bruton's tyrosine 
kinase  (Btk) 1 are responsible for X-linked agamma- 
globulinemia (XLA), a severe primary immunodeficiency of 
boys characterized by the virtually complete absence of cir- 
culating B  lymphocytes. An  early developmental block is 
evidenced by an increase in pro-B cells and inefficient ex- 
pansion and proliferation ofpre-B cells in the bone marrow 
(for reviews see references 1,  2).  A  point mutation in the 
NH2-terminal  pleckstrin  homology  (PH)  domain  of the 
murine Btk causes a less severe X-linked immunodeficiency 
(Xid)  of CBA/N mice  (3,  4).  Comparison of the pheno- 
types seen in XLA and Xid  suggested the  possibility that 
murine Xid mutation may not be a complete loss of func- 
tion.  Analyses  of recently established btk  -/-  mice  (5,  6), 
however,  prove  that  lack  of Btk  function  results  in Xid 
phenotypes and suggest a differential requirement for Btk 
between murine and human B cell development. 
Btk,  along  with  Tec  and  Itk,  comprises  the  Tec/Btk 
subfamily of Src-related tyrosine kinases  (7-13). Btk has a 
unique NH2-terminal region containing a PH domain and 
a proline-rich stretch, followed by Src-homology (SH) 3, 
SH2, and kinase domains (14, 15). SH3 domains have been 
1Abbreviations used in  this paper: BCR, B cell antigen receptor;  Btk, Bru- 
ton's tyrosine  kinase; IP3, inositol  1,4,5-trisphosphate; ITAM, immunore- 
ceptor tyrosine-based  activation  motif, MAPK, mitogen-activated  protein 
kinase; PH, pleckstrin  homology;  PI, phospatidylinositol;  PLC, phospho- 
lipase C; SH, Src homology; Xid, X-linked immunodeficiency;  XLA, 
X-linked agammaglobulinemia. 
shown to interact with proteins containing a short proline- 
rich motif, whereas SH2 domains interact with motifs con- 
taining phosphorylated tyrosine residues  (for a review see 
reference 16).  The PH domains have been found in many 
proteins  involved in  intracellular signaling  pathways  and, 
although of unknown function, have been speculated to be 
involved in protein-protein interactions. XLA patients dis- 
play heterogeneity in mutations,  which include deletions, 
insertions,  and substitutions.  Mutations  in  the  kinase  do- 
main,  as well as genetic alterations affecting PH,  SH3,  or 
SH2 domains can lead to the XLA phenotype (1,  2,  17). 
These observations indicate that multiple  protein-protein 
interactions are essential for Btk function. 
Xid mice are unable to respond to thymus-independent 
type II antigens  (18,  19).  In vitro studies also have shown 
that Xid B  cells do not proliferate when triggered through 
their surface B cell receptor for antigen (BCR) (20, 21) and 
show hyporeactivity to LPS stimulation (19,  22). Inactiva- 
tion by homologous recombination of  membrane Igix or of 
surrogate light chain encoding the k5 gene leads to a block 
in progression from the pro-B cell to pre-B cell (23,  24), 
generating a phenotype in mice that resembles that seen in 
XLA patients. Thus, it is speculated that Btk is involved in 
the  signaling  activity through pre-B  cell receptor as well 
as BCR. 
The BCR complex contains, in addition to mlg, a hetero- 
dimer of Iga/Ig[3, which is essential for signal transduction 
(for a review see reference 25). The BCK is endowed with 
a tyrosine kinase function by associating Src-family kinases, 
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26-29).  Src-family kinases are rapidly activated after BCR 
engagement  (30,  31),  and  their  activation  correlates with 
the initial tyrosine phosphorylation of the immunoreceptor 
tyrosine-based activation motif (ITAM)  on  the BCR  IgoL 
and  Ig[3  subunits.  Syk  is  recruited  to  the  phosphorylated 
Igo~/Ig[3  ITAM  (32)  and is subsequently phosphorylated by 
Src  kinase-mediated  transphosphorylation  and  autophos- 
phorylation at the 518 and/or 519 tyrosine sites, leading to 
the  activation  of Syk  (33).  In  addition to  Src  kinase  and 
Syk, it has been shown  that Btk is also activated after liga- 
tion of the BCR  in mature  and immature B  cells (34-37) 
and  may  be  constitutively  activated  in  pre-B  cells  (34). 
However, none of its in vivo substrates have thus far been 
identified. 
Here we report that BCR-induced phosphatidylinositol 
(PI)  hydrolysis and  calcium mobilization are  abolished in 
Btk-deficient DT40  B  cells.  Induction  of tyrosine  phos- 
phorylation of phospholipase C  (PLC)-',/2 was significantly 
reduced in Btk-deficient cells. These  observations provide 
the  evidence  that  PLC-y2  could  be  a  potential  target  of 
Btk  and  support  a  model  for  the  action  of at  least  three 
types of protein tyrosine kinases in BCR  signaling. 
Materials  and Methods 
Cells, Expression Constructs, and Abs.  Wild-type DT40 and its 
mutant cells were cultured in RPMI 1640 medium supplemented 
with 10% FCS, antibiotics, and glutamine. Human Btk cDNA was 
obtained from UK DNA probe bank (Human Genome Mapping 
Project Resource  Centre,  Harrow,  Middlesex, UK).  Mutations 
in PH,  SH2, or kinase domains were introduced by PCR using 
PFU polymerase (Stratagene Inc., La Jolla, CA), confirmed by se- 
quencing,  and  subcloned  into  expression vector pApuro  (38). 
Transfection into Btk-deficient cells was done by electroporation. 
Clones were selected in the presence ofpuromycin (0.5  txg/ml), 
and expression of Btk cDNA was verified by Western blotting. 
Anti-chicken IgM mAb M4,  anti-PLC-3,2 serum,  and anti-Syk 
serum were previously described (39).  Anti-Btk mAb,  anti-Cbl 
Ab, anti-mitogen-activated protein kinase (MAPK) Ab, anti-Shc 
Ab,  and  antiphosphotyrosine mAb 4G10  were purchased from 
PharMingen  (San  Diego,  CA),  Santa Cruz Biotechnology, Inc. 
(Santa  Cruz,  CA),  New  England  Biolabs,  Inc.  (Beverly, MA), 
Upstate Biotechnology, Inc. (Lake Placid, NY), and Upstate Bio- 
technology, Inc., respectively. 
Generation of Btk- and Lyn/Syk-defident DT40 Cells.  Chicken  btk 
cDNA clones were isolated from a chicken spleen cDNA library 
(Clontech Inc., Palo Alto, CA) using human btk cDNA fragment 
as a  probe under  a low  stringent condition.  Chicken btk  7-kb 
EcoRI genomic clone was obtained by screening a genomic li- 
brary that was constructed by ligating EcoRI-digested DT40 ge- 
nomic  DNA  (,~'6 to  ~9  kb)  with vector arms  of the  Lambda 
ZAP II (Stratagene, Inc.). The targeting vectors, pcBTK-neo and 
pcBTK-hisD,  were  constructed by replacing the  0.7-kb  BgllI- 
BamHI  genomic fragment containing exons that correspond to 
human Btk amino acid residues 91-124 with neo or hisD cassette. 
The targeting vector pcBTK-neo was linearized and introduced 
into wild-type DT40 cells by electroporation. Selection was done 
in  the  presence  of 2  mg/ml  G418.  Clones  were  screened  by 
Southern blot analysis using 3' flanking probe (0.5-kb BgllI-BglIl 
fragment).  The  neo-targeted  clone  was  again  transfected  with 
pcBTK-hisD and selected with both G418  (2 mg/ml) and histi- 
dinol  (1  mg/ml).  For generation  of Lyn/Syk  double-deficient 
cells,  the targeting vector pSyk-blasticidin S resistance (bsr) was 
made by replacing the  neo gene  of pSyk-neo (38)  with  the bsr 
gene  (Funakoshi, Tokyo, Japan)  (40)  and transfected into  Lyn- 
deficient cells (38).  Clones were selected in the presence of 50 
Ixg/ml blasticidin S. Correct targeting was confirmed by reprob- 
ing the blots with internal neo, hisD, or bsr probe. 
Immunoprecipitation and  Western Blot Analysis.  Cells were  sol- 
ubilized in lysis buffer (1%} NP-40,  150 mM NaC1,  20 mM Tris, 
pH  7.5,  and  1  mM  EDTA)  containing 50  mM  NaF,  10  txM 
molybdate,  and  0.2  mM  sodium  vanadate  supplemented  with 
protease inhibitors (1  mM PMSF,  2  mg/ml aprotinin, 0.5  mM 
benzamidine hydrochloride, 10 mg/rnl chymostatin, 0.1 mM Nix- 
p-tosyl-L-lysine chlorometyl ketone (TLCK), 0.1 mM N-l-tosyl- 
amide-2-phenylethylethylchlorometyl ketone  (TPCK),  10  mg/ml 
leupeptin, 10 mg/ml antipain,  10 mg/ml calpain inhibitor I, and 10 
mg/ml pepstatin)  (41).  For immunoprecipitation, precleared ly- 
sates were sequentially incubated with Abs and protein A-agarose. 
Lysates or immunoprecipitates were separated by SDS-PAGE gel, 
transferred to nitrocellulose membrane,  and detected by appro- 
priate Abs and the  enhanced  chemiluminescence  system  (ECL); 
(Amersham Corp., Arlington Heights, IL). Deprobing and reprob- 
ing  were  done  according to  the  manufacturer's  recommenda- 
tions. To  examine in vitro kinase activity of human  Btk and its 
mutants, immunoprecipitated Btk was suspended in kinase buffer 
(20 mM Tris, pH 7.5,  10 mM MgC12, and 0.1%  Triton X-100) 
containing ~/-[32p]ATP  (>3,000  Ci/mmol;  Amersham  Corp.), 
and incubated at room temperature for 10 rain. For in vitro ki- 
nase assay of Lyn and Syk (see Fig. 4), cells were lysed in modified 
radioimmunoprecipitation assay (RIPA) buffer (1% NP-40, 0.25% 
sodium deoxycholate, 150 mM NaC1,  20 mM Tris, pH 7.5, and 
I  mM EDTA) supplemented with the phosphatase and protease 
inhibitors described above,  hnnmnoprecipitates were suspended 
in kinase buffer (20 mM Tris, pH 7.4, 10 mM MnCI  2 for Lyn, or 
20 mM Hepes, pH 8, 150 mM NaC1, and 10 mM magnesium ac- 
etate  for  Syk)  containing ",/-[32p]ATP,  and  incubated  at  room 
temperature for 10 rain. 
Northern Blot Analysis.  RNA was prepared from wild-type and 
mutant DT40 cells using the guanidium thiocyanate method. To- 
tal RNA  (20  ~g)  was separated by 1.5%  agarose, transferred to 
Hybond-N membrane,  and probed with  a  chicken Btk  cDNA 
fragment. 
Calcium Measurements.  Cells (5 ￿  106) were suspended in PBS 
containing 20 mM Hepes, pH 7.2, 5 mM glucose, 0.025% BSA, 
and 1 mM CaC12, and loaded with 3 IxM Fura-2/AM at 37~  for 
45  min.  Cells were washed twice and adjusted to  106  cells/nil. 
Continuous monitoring of fluorescence from the cell suspension 
was performed using a  fluorescence spectrophotometer (model 
F-2000; Hitachi, San Jose, CA) at an excitation wavelength of 340 
nm and an emission wavelength of 510  nm. Calibration and cal- 
culation of calcium levels were done as described (42). 
PhosphoinositideAnalysis.  Cells  (106/ml)  were  labeled  with 
myo-[3H]inositol (10  txCi/ml, 105  Ci/mmol; Amersham Corp.) 
for 5-6  h  in inositol-free RPMI-1640  supplemented with  10% 
dialyzed FCS, then  stimulated in  the  presence  of 10  mM  LiC1 
with  M4  mAb.  The  soluble inositol phosphates were  extracted 
with TCA at indicated time points, and applied to AG1-X8 (for- 
mate form) ion exchange columns (Bio-Rad Laboratories, Rich- 
mond, CA) preequilibrated with 0.1 M formic acid. The colunms 
were washed with 10 ml water and 10 nil of 60 mM ammonium 
32  Function ofBruton's Tyrosine Kinase in B Cell Receptor Signaling Figure 1.  Disruption of the btk gene in chicken B cell 
line DT40. (A) Partial restriction map of chicken btk locus. 
(B) Targeting constructs. (C) Predicted structure of the tar- 
geted btk alleles. Only disrupted exons are shown as black 
boxes. The restriction endonuclease cleavage sites are ab- 
breviated: B, BamHI; Bg, BgllI; E, EcoRl. (D) Southern 
blot analysis  of genomic DNA from wild-type DT40 cells 
(+/+, lane 1), neo-targeted cells (+/-, lane 2), and neo- 
and hisD-targeted  cells (-/-,  lane 3). Genomic DNA was 
digested by EcoP,.I. (E)Western blot analysis  of Btk protein 
expression in  wild-type  and  targeted  DT40  cells. Cells 
were lysed by NP-40 buffer, separated by 8% SDS-PAGE 
gel. The blotted membrane was incubated with  anti-Btk 
Ab. (F) R.NA expression was analyzed by Northern  blot 
analysis  using chicken cDNA probe for Btk (top) or 13-actin 
(bottom). Positions of 28S and 18S P,  NA are shown. 
formate/5 mM sodium tetraborate. Elution was performed with 
increasing concentrations of ammonium formate (0.1-0.7 M) (43). 
How Cytometric Analysis for Surface Expression of BCR.  Cells  were 
washed, stained with FITC-conjugated anti-chicken IgM (Bethyl 
Laboratories, Inc., Montgomery, TX) , and analyzed by FACSort 
(Becton Dickinson & Co., Mountain View, CA). 
Results 
To  disrupt the Btk  gene, targeting constructs containing 
neomycin or histidinol resistance gene cassette were sequen- 
tially transfected into chicken B  cell line DT40  (Fig.  1  B). 
Screening  by  Southern  blot  analysis identified  two  inde- 
pendent clones that underwent homologous recombination 
at both  btk  loci (Fig.  1  D).  Hybridization with  a  neo  and 
hisD probe indicated that the  targeted clone had incorpo- 
rated a single copy of each construct (data not shown). Lack 
of Btk expression was confirmed by Northern and Western 
blot analyses in these clones (Fig. 1, E  and F). Another mu- 
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tant  cell line  that  was  deficient in  both  Lyn and  Syk was 
also established by disrupting syk gene in Lyn-deficient cells 
(38).  Flow  cytometric analysis showed  that BCR  expres- 
sion  on  all  of these  mutant  cell fines  was  essentially the 
same level as that of parental DT40 cells (Fig. 2). 
Engagement of BCR  rapidly activates protein tyrosine ki- 
nases, leading to the induction of tyrosine phosphorylation 
on a number of cellular proteins. To characterize early sig- 
naling events through BCR  stimulation, we  evaluated the 
induction of tyrosine phosphorylation in whole cell lysates 
of Btk-deficient cells in response to stimulation by anti-IgM 
mAb  M4.  There  were  no  significant differences between 
wild-type  and  Btk-deficient  cells  by  antiphosphotyrosine 
Western blot (Fig. 3).  Cells deficient in both Lyn and Syk 
(Lyn/Syk double-deficient cells), which express Btk, showed 
an  almost  complete  defect in  induction  of tyrosine phos- 
phorylation. This tyrosine phosphorylation pattern was es- 
sentially the same as that ofBCR-deficient DT40 cells (data 
not shown).  These data, together with our previous results ..Q 
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Figure 2.  Cell surface expression of  BCP,. on various DT40 mutants. Unstained cells were used as negative controls. Btk-deficient cells expressing  wild 
type, SH2, PH, and kinase mutants of  Btk are indicated as wt/btk-, mSH2/btk  , mPH/btk-, and K-/btk-, respectively. 
(38),  demonstrate  that Lyn and Syk, not Btk,  are primarily 
responsible  for overall  induction  of tyrosine  phosphoryla- 
don on multiple cellular substrates upon BCR  stimulation. 
Btk-deficient  cells  allowed  us  to  examine  the  effects  of 
Btk  on BCR.-induced  Lyn and  Syk activation.  We  previ- 
ously showed  that receptor-induced  tyrosine  phosphoryla- 
tion of Cbl and  Syk is mediated by Lyn (44,  45).  Thus,  to 
determine the effects of Btk on Lyn activation, induction  of 
Figure  3.  Tyrosine phosphorylation of whole cell proteins in Btk- and 
Lyn/Syk-deficient DT40 cells. At the indicated time points after stimula- 
tion with M4 (4 I.tg/ml), whole cell lysates (2.5 ￿  106 cells) were pre- 
pared using SDS sample buffer, and loaded onto 8% SDS-PAGE gel. The 
blotted membrane was incubated with antiphosphotyrosine mAb. 
phosphorylation  of these  molecules  was  examined  in  wild- 
type and Btk-deficient  cells.  As shown in  Fig.  4,  B  and  C, 
the  BCR-induced  tyrosine  phosphorylation  of both  Cbl 
and Syk was not affected by the loss of  Btk, although tyrosine 
phosphorylation of Cbl at 10 rain was a little increased com- 
pared with wild-type cells.  Furthermore,  tyrosine phosphor- 
ylation of Lyn upon receptor ligation  in Btk-deficient  cells 
was similar to that of wild-type cells (Fig. 4 A). These obser- 
vations indicate  that BCR-induced  activation  of Lyn is in- 
dependent  of Btk.  To determine  the  effects of Btk on Syk 
activation,  we monitored  tyrosine phosphorylation  of Shc, 
since  receptor-induced  phosphorylation  of Shc  is  depen- 
dent  on  Syk  (46).  Loss  of Btk  did  not  affect  the  tyrosine 
phosphorylation  of Shc  (Fig.  4  D),  demonstrating  that Syk 
activation  is also  independent  of Btk.  To  strengthen  these 
conclusions, in vitro kinase assay of Lyn and Syk after BCR 
stimulation  was carried  out in wild-type  and Btk-deficient 
cells. As shown in Fig. 4,  E  and F, no differences were ob- 
served between wild-type and mutant cells. 
Wild-type  DT40  cells  show  a  brisk  elevation  of intra- 
cellular calcium levels after BCR  stimulation,  whereas Btk- 
deficient  cells  completely  abrogated  this  calcium  response 
(Fig.  5  A). As shown in Fig.  5  B, the BCR-induced  inosi- 
tol  1,4,5-trisphosphate  (IP3)  generation was also completely 
abolished in the mutant cells, indicating that Btk is essential 
for PLC-~/2 activation.  Since these early events are known 
to  be  dependent  on  tyrosine  phosphorylation  of PLC-~2 
(39), induction  of tyrosine phosphorylation of PLC-~/2 was 
examined.  Although  Btk-deficient  cells  still  induced  ty- 
rosine phosphorylation  of PLC-'y2 upon BCR  ligation,  its 
extent  was  clearly lower  (about  threefold)  and  more  tran- 
sient  than  that  of wild-type  cells  (Fig.  5  C).  These  results 
suggest that Btk mediates phosphorylation  of tyrosine resi- 
due(s)  of PLC-'y2 which is critical for PLC-~/2 activation. 
34  Function ofBruton's Tyrosine Kinase in B Cell Receptor Signaling Figure 4.  Activation of Lyn  and Syk in wild- 
type and Btk-deficient DT40 cells. Tyrosine phos- 
phorylation ofLyn, Syk, Cbl, and Shc (A-D) and in 
vitro kinase activi  W of Lyn and Syk (E,  b) upon 
BCR engagement. At the indicated time points af- 
ter M4 stimulation (4 bLg/ml),  cells  were lysed  in 1% 
NP-40  lysis  buffer, and immunoprecipitated with 
anti-Lyn (.4), anti-Syk (B), anti-Cbl  (C), or anti- 
Shc Abs (D). Immunoprecipitates were loaded onto 
8% SDS-PAGE gel, and the blotted membrane was 
incubated with antiphosphotyrosine mAb. After the 
filter was stripped, the same blot was reprobed with 
Abs that were used for immunoprecipitation  (bot- 
tom). For in vitro kinase assay, cells  were lysed by 
modified  RIPA  buffer, and  immunoprecipitated 
with anti-Lyn (E) and anti-Syk (F) Abs. Immuno- 
precipitated were divided, and half of them were 
used for in vitro kinase assay. The remaining half 
were used for Western blotting. SampIes  were eIec- 
trophoresed on 8% SDS-PAGE gels. 
BCR  engagement results in the activation of at least two 
divergent  signaling pathways  (for  a  review  see  reference 
47).  The  first is activation of PLC-~/2  and a  second path- 
way involves Ras with subsequent phosphorylation and ac- 
tivation  of MAPK.  The  contribution  of Btk  to  the  Ras 
pathway was measured by the ability of the BCR  to medi- 
ate activation of MAPK. Activation of MAPKs is mediated 
by phosphorylation of Thr  and  Tyr  residues within  their 
catalytic domains  (48).  Cross-linking of the BCR  in both 
wild-type and mutant cells resulted in activation of MAPK 
as measured by immunoblotting with an Ab that recognizes 
only the activated forms of MAPK (Fig. 6), suggesting that 
Btk is not essential for coupling the BCR to the Ras pathway. 
Btk has a  unique NH2-terminal region containing a PH 
domain and a proline-rich stretch, followed by SH3, SH2, 
and kinase domains (14,  15). To examine whether mutated 
Btk  exhibits  a  functional  defect  through  BCR  signaling, 
human Btk cDNA harboring mutations either in PH (Arg  2s 
to Cys), SH2  (Arg  307 to Ala), or kinase (Arg  5z5 to Gln) do- 
mains were  transfected into Btk-deficient cells (Fig. 7  A). 
In  addition,  wild-type Btk  was  introduced  into  the  Btk- 
deficient cells. BCR-induced calcium mobilization and PI 
hydrolysis were  examined  in  the  transfectants  expressing 
similar levels  of Btk  among  wild-type and  these  mutants 
(Fig. 7  B). As expected, only the kinase domain mutant ab- 
rogated its in vitro kinase activity (data not shown). Expres- 
sion levels of BCR  on  these  transfectants  were  similar to 
those of wild-type cells (Fig. 2). 
Upon  BCR  stimulation,  Btk-deficient  cells  expressing 
wild-type Btk (wt/btk-) evoked even more vigorous calcium 
mobilization and IP  3 generation than wild-type cells, con- 
firming the role of Btk in PLC-'y2 activation. In contrast, 
transfectants expressing Btk mutants in the PH (mPH/btk-), 
SH2  (mSH2/btk-),  or kinase  (K-/btk-)  domain showed  a 
much  smaller  calcium  response  and  IP  3  generation  after 
BCR  ligation (Fig. 8, A  and B). Consistent with these data, 
35  Takata and Kurosaki Figure  5.  Calcium mobilization, IP  3 generation, and ty- 
rosine phosphorylation of PLC-y2 in wild-type  and Btk- 
deficient DT40 cells. (A) Intracellular free calcium levels in 
Fura-2-1oaded cells were monitored by a spectrophotome- 
ter after stimulation with M4 (2 Ixg/ml). (B) For IP  3 detec- 
tion, soluble inositol  was extracted  from  cells stimulated 
with  M4 (2 txg/ml) and subjected to AG1-X8 anion ex- 
change columns. (C-') Tyrosine phosphorylation of PLC-y2 
was carried out as described in the legend to Fig. 4. 
only wild-type Btk restored the BCR-induced tyrosine phos- 
phorylation of PLC-y2  that  was  seen  in wild-type  DT40 
cells  (Fig.  8  C).  These  results  establish the  importance  of 
PH,  SH2, and kinase domains of Btk in PLC-y2 activation 
through BCR  stimulation, and correlate well with the fact 
that mutations of these Btk residues (Arg  a8 to Cys, Arg  3~  to 
Gly,  and  Arg  s2s  to  Gin)  cause  a  typical  XLA  phenotype 
(15,  49,  50).  The  residual  calcium  mobilization  and  IP  3 
generation might  be  due  to  overexpression  of these  mu- 
tants, because cells expressing lower amounts of PH,  SH2, 
or kinase domain mutant showed an almost flat calcium re- 
sponse (data not shown). 
Figure 6.  MAPK activation in wild-type and Btk-deficient cells. Cells 
were stimulated with M4 (4 p.g/ml). Cell lysates  were then analyzed  by im- 
munoblotting  with anti-phospho MAPK (top) or anti-MAPK (bottom) Abs. 
Discussion 
Lyn/Syk double-deficient cells exhibited an almost com- 
plete defect in induction of tyrosine phosphorylation upon 
BCR  ligation, indicating that activation of Lyn and Syk can 
account  for  the  vast  majority of the  initial tyrosine phos- 
phorylation of cellular substrates.  Our  results  demonstrate 
36  Function ofBruton's Tyrosine Kinase in B Cell Receptor Signaling Figure 7.  Schematic representation of Btk cDNA constructs (A) and 
expression of transfected Btk in Btk-deficient DT40 cells (B). DT40 cells 
(0.5 ￿  106 cells/lane) expressing  indicated constructs  were lysed  with NP-40 
buffer and electrophoresed on 8% SDS-PAGE gel, transferred to nitrocel- 
lulose, and incubated with anti-Btk Ab. 
that activation of Lyn is independent  of Btk upon receptor 
ligation.  Supporting  this  concept,  Btk  has been  shown  to 
be  activated  after  the  activation  of Src  kinases  (35).  Since 
Btk activation precedes Syk activation in BCR signaling (35), 
it is  speculated  that Btk may regulate  Syk activation upon 
receptor  stimulation.  However,  Syk activation, judged by 
its in vitro kinase activity (Fig. 4 F), was not affected by loss 
of Btk.  This  conclusion is  further  supported by no differ- 
ences  of the  BCR-induced  phosphorylation  of Shc  be- 
tween wild-type and mutant cells  (Fig. 4  D), since we pre- 
viously  showed  that  Shc  phosphorylation  is  mediated  by 
Syk upon BCR engagement (46). Because recnaitment of  Syk 
to  tyrosine-phosphorylated  Iga/Igl3 ITAM is  essential  for 
Syk activation in BCR signaling (26-28, 33), these data also 
suggest that tyrosine phosphorylation of IgoL/Igl3 ITAM is 
not dependent on Btk. 
In contrast to Lyn- and  Syk-deficient DT40  cells,  Btk- 
deficient cells  exhibited almost the same pattern of tyrosine 
phosphorylation  of cellular  proteins  as  the  wild-type  cells 
upon BCR  cross-linking.  This might reflect differences in 
localization of these kinases for coupling the BCR to down- 
stream substrates.  Both Lyn and Syk are associated with the 
BCR components before and after receptor stimulation,  re- 
spectively (26-28),  whereas no association of Btk with the 
receptor complex was detected to date. 
Involvement of the Syk kinase in BCR-induced PLC-~/2 
phosphorylation is certain: Syk-deficient DT40 cells exhibit 
an almost complete loss of PLC-'y2 tyrosine phosphorylation 
upon BCR stimulation (38). The data presented here show 
that Btk  also  participates  in  this  phosphorylation.  In con- 
trast to Syk-deficient cells,  the extent ofBCR-induced ty- 
rosine  phosphorylation  of PLC-~/2  in  Btk-deficient  cells 
was about threefold less than that of wild-type cells.  These 
results implicate that Syk and Btk may regulate one another 
in PLC-~/2 phosphorylation. As mentioned above, our data 
suggest that Syk activation is not dependent on Btk in BCR 
signaling. Thus, it is possible that Syk regulates Btk in BCR- 
mediated PLC-"/2 activation. Recent reports by others (51, 
52)  have shown that in contrast to Src kinase,  Syk is inca- 
pable  of activating Btk kinase in COS cells and fibroblasts. 
However,  since  activation  of Syk requires  the presence  of 
Figure 8.  Functional restoration of  BCR signaling by various Btk mutants. Calcium mobilization (A), IP  3  generation (B), and tyrosine phosphorylation 
ofPLC-~/2 (C) were examined as described in the legend to Fig. 5. (C) Cells were stimulated for 3 rain with M4 (4 p~g/ml). 
37  Takata and Kurosaki Src kinase (45), this differential requirement for Btk activation 
might reflect relative kinase activity in these cells rather than 
specificity between Src kinase and Syk. In the context of BCR 
signaling, it remains possible that Lyn-activated Syk may fur- 
ther enhance Btk kinase activity. Alternatively,  activation of 
Syk and Btk may be mutually independent.  Thus, at present, 
we  can  only say that  these  two  kinases  act  in  concert  for 
PLC-y2 tyrosine phosphorylation. 
Both Syk and Btk are required for PLC-y2 activation aRer 
BCP,  stimulation.  It is known  that  three  distinct  tyrosine 
phosphorylation sites of PLC-yl  are required for its activa- 
tion  through  growth  factor  receptors  such  as  platelet- 
derived growth factor receptor  (53).  Thus,  the  most likely 
explanation is that phosphorylation of these critical tyrosine 
sites of PLC-"/2 are mediated distinctly by Syk and Btk upon 
receptor hgation. In contrast to the complete block of BCR.- 
induced PI hydrolysis in Btk-deficient chicken DT40  cells, 
B  cells from Xid mice show reduced (40-50%)  PI hydrolysis 
compared with normal B cells (54). This observation impli- 
cates that murine Btk is also involved in PLC-',/activation 
at least to some extent, and that the distinct stringency of Btk 
requirement for PLC-y activation may represent a species dif- 
ference between chicken and mouse. One possible mecha- 
nism for this difference is another tyrosine kinase that sub- 
stitutes  for Btk function  in Xid mice.  Alternatively,  DT40 
cells express exclusively PLC-y2 isoform (39), whereas both 
PLC-~/1 and PLC-~2 may be expressed in mouse B  cells. In 
contrast to PLC-y2,  PLC-',/1  may require  only Syk for its 
activation, obviating a stringent requirement for Btk in mouse 
as a whole PLC-',/activation. 
Our data indicate that Btk activation requires its PH and 
SH2 domains in BCR signaling, suggesting that interactions 
of these  domains  to proteins  and/or  selected lipids  are  es- 
sential for Btk activation after BCR hgation. Given the im- 
portance of SH2 domain in signal transduction (16), Btk may 
be activated by its recruitment to a phosphorylated molecule. 
Indeed, in the case of Lyn and Syk, it was reported that bind- 
ing of their SH2 domains to phosphorylated ITAM increases 
the  kinase activity in vitro  (32,  55).  The COOH-terminal 
region  of the PH domain has been shown to interact with 
the  [3/~/subunits  of trimeric  G  proteins  (56,  57).  Also,  the 
NH2-terminal region of several PH domains has been shown 
to  bind  the  membrane  lipid  PI-4,5-bisphospate  (58),  im- 
plying a role in membrane localization.  Supporting this pos- 
sibility, a gain-of-function mutant in the PH domain of Btk 
shows an increase in membrane targeting  and an increase in 
phosphorylation on tyrosine residues (59). Thus, our data sug- 
gest that these interactions  through  the PH domain  of Btk 
is also required for PLC-y2 phosphorylation,  leading to its 
activation. 
Both pre-BCP, and BCP, associate with Igor and Ig[3 chains 
that are involved in initiating  signaling  cascades  (60).  R.e- 
cent genetic evidence that tyrosine residue of Igxx/Ig~ ITAM 
is essential for B  cell development (61, 62) have implicated a 
direct link between  development  and  ITAM-induced  sig- 
naling in B  cells. Thus,  the requirement  of Btk for PLC-~/ 
activation through Igo~/Ig~3 ITAM may offer a biochemical 
explanation  for the  defective B  cell  development  in  XLA 
patients and Xid mice. 
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